PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Department of Medical Biology, Faculty of Health Science, UiT Arctic University of Norway, N-9037 Tromsø, Norway.\', \'Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.\', \'Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.\', \'Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.\', \'Transplantation Research Center, Renal Division, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, United States.\', \'Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: asatyam@bidmc.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(21)00132-710.1016/j.clim.2021.108795
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 34252574
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all